Fennec Pharmaceuticals ( (TSE:FRX)) just unveiled an update. Fennec Pharmaceuticals announced the pricing of its public offering of 4,666,667 common shares at $7.50 per share, expecting to raise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback